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dant-mediated tissue injury is key to the pathogenesis of acute lung
injury. Glutathione-S-transferases (GSTs) are important detoxifying
enzymes that catalyze the conjugation of glutathione with toxic
oxidant compounds and are associated with acute and chronic inflam-
matory lung diseases. We hypothesized that attenuation of cellular
GST enzymes would augment intracellular oxidative and metabolic
stress and induce lung cell injury. Treatment of murine lung epithelial
cells with GST inhibitors, ethacrynic acid (EA), and caffeic acid
compromised lung epithelial cell viability in a concentration-depen-
dent manner. These inhibitors also potentiated cell injury induced by
hydrogen peroxide (H2O2), tert-butyl-hydroperoxide, and hypoxia and
reoxygenation (HR). SiRNA-mediated attenuation of GST- but not
GST- expression reduced cell viability and significantly enhanced
stress (H2O2/HR)-induced injury. GST inhibitors also induced intra-
cellular oxidative stress (measured by dihydrorhodamine 123 and
dichlorofluorescein fluorescence), caused alterations in overall intra-
cellular redox status (as evidenced by NAD/NADH ratios), and
increased protein carbonyl formation. Furthermore, the antioxidant
N-acetylcysteine completely prevented EA-induced oxidative stress
and cytotoxicity. Whereas EA had no effect on mitochondrial ener-
getics, it significantly altered cellular metabolic profile. To explore the
physiological impact of these cellular events, we used an ex vivo
mouse-isolated perfused lung model. Supplementation of perfusate
with EA markedly affected lung mechanics and significantly in-
creased lung permeability. The results of our combined genetic,
pharmacological, and metabolic studies on multiple platforms suggest
the importance of GST enzymes, specifically GST-, in the cellular
and whole lung response to acute oxidative and metabolic stress.
These may have important clinical implications.
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ACUTE LUNG INJURY (ALI) and acute respiratory distress syn-
drome (ARDS) are life-threatening inflammatory disorders,
which may result from both medical and surgical situations
such as sepsis, heart surgery, and lung transplantation (41).
Among these, ischemia and reperfusion injury constitutes a
unique entity, wherein metabolic and oxygen starvation and
subsequent reoxygenation can lead to the release and accumu-
lation of reactive oxygen species (ROS) (4). ROS can directly
oxidize and damage DNA, protein, and lipid membranes,
inactivate antioxidant enzymes, and enhance expression of
proinflammatory genes, ultimately leading to cell injury and
apoptosis (11).
The glutathione-S-transferase (GST) antioxidant enzymes
form a multifunctional superfamily of intracellular isozymes
that catalyze the conjugation of reduced glutathione (GSH)
with a variety of toxic compounds, including xenobiotics and
oxidative intermediates (such as lipid and DNA hydroperox-
ides and aldehydes) (17, 18). This renders them less toxic and
facilitates their removal from the cell (17, 18). Their key role
in cellular detoxification protects macromolecules from attack
by reactive electrophiles, such as ROS products, environmental
carcinogens, and chemotherapeutic agents. Increasing evidence
suggests that GST expression and function are important in
both cancer progression (24, 39) and acute inflammatory con-
ditions (23). For example, Luo et al. (23) demonstrated that
treatment of mice with recombinant GSTP1 attenuated LPS-
induced acute inflammation.
The clinical importance of diminished endogenous GST
expression and activity is emerging. At least five of the eight
GST genes in humans have functional polymorphisms where
substitutions or deletions affect enzyme expression and activity
and are present in up to 50% of the population (16). Such
polymorphisms are believed to contribute to individual differ-
ences in the clearance of xenobiotics and oxidative stress
products and to susceptibility to various inflammatory and
proliferative pathologies (16). For instance, individuals with
homozygous GSTM1 gene deletions appear to be more sus-
ceptible to DNA damage induced by GSTM1 substrates (32)
and are more at risk of developing lung adenocarcinoma (7).
Preliminary clinical studies also suggest that attenuated GST
expression may contribute to ALI (25). Moradi and colleagues
(25) showed that GSTM1 polymorphisms were associated with
increased mortality in critically ill patients with ALI/ARDS. In
the setting of lung transplantation, donor GST polymorphisms
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dramatically increased the development of primary graft dys-
function (8, 14). Despite these suggestions, the exact role of
GST attenuation in lung cell injury, the basic mechanisms
involved, and the relative impact of different GST isozymes
are not known.
We hypothesized that GST attenuation would lead to in-
creased intracellular oxidative stress affecting mitochondrial
energetics and cellular metabolism, resulting in lung cell in-
jury. To test these ideas, we studied the influence of pharma-
cological inhibitors ethacrynic acid (EA) and caffeic acid (CA)
(1, 28, 29, 37, 49) and RNA silencing of GST isoforms on lung
epithelial cell survival, ROS generation, and energetic/meta-
bolic status in murine cell culture models of ALI. Finally, the
physiological impact of GST inhibition was also explored
using an ex vivo murine-isolated perfused lung (IPL) model by
focusing on potential effects on lung mechanics and permea-
bility.
MATERIALS AND METHODS
Cell culture. Murine lung epithelium (MLE)-12 cells (ATCC,
Rockville, MD) were grown in Hanks medium (F12:MEM) supple-
mented with 1% penicillin/streptomycin and 5% fetal calf serum at
37°C in humid conditions with 5% CO2-95% air. For hypoxia and
reoxygenation (HR) experiments, we used deoxygenated culture me-
dium (bubbled with 95% N2-5% CO2 gas mixture under sterile
conditions) and a hypoxic chamber (Mini Galaxy A; Wolf Laborato-
ries, York, UK). Cells were exposed to hypoxic conditions for 12 or
24 h. Subsequently, medium was exchanged for fresh, prewarmed,
oxygenated medium, and cells were exposed to normoxic conditions
for increasing periods of reoxygenation (2, 6, 12, or 24 h).
GST inhibition: method and efficacy. The pharmacological agents
EA and CA were employed to attenuate activity of purified bovine
liver GST (350 mU) or endogenous GSTs in cell lysates. The degree
of inhibition was evaluated using the GST fluorometric activity assay
kit (Biovision, Mountain View, CA). A linear increase in fluorescence
at excitation/emission (ex/em) 380/460 nm was measured over the
initial 10-min period and calculated as fluorescence U (FU)/min. A
standard calibration curve was used to determine GST activity (mU)
in unknown samples.
To complement the pharmacological data, we employed RNAi to
specifically knockdown GST- or - isoforms. This was achieved
using predesigned GST- and - ON-TARGETplus Smartpool
siRNA (Dharmacon siRNA Technologies, Thermo Scientific, Glas-
gow, UK). In brief, 20 pmol of scrambled control or GST-targeting
siRNA was introduced into MLE cells using Lipofectamine 2000
(Invitrogen, Carlsbad, CA). After 5 h, the siRNA-Lipofectamine
medium was replaced with fresh medium, and cells were incubated for
an additional 48 h before further experimentation.
The extent of siRNA-mediated knockdown of GST expression was
evaluated by RT-PCR. Total RNA was extracted from transfected
cells using the RNAeasy mini kit (Qiagen, Valencia, CA) (13) and
quantified spectrophotometrically (Biophotometer Plus; Eppendorf,
Stevenage, UK). Single-stranded cDNA was synthesized from 2 g
RNA with TaqMan RT-PCR reagents using GeneAmp PCR System
9700 (Applied Biosystems, Warrington, UK) (13). The cycling
conditions were 25°C for 10 min, 48°C for 30 min, and 95°C for
5 min. cDNA was amplified using the TaqMan gene expression
master mix (Applied Biosystems) and TaqMan probes specifically
targeted against mouse GST- (Mm00833915_g1) and GST-
(Mm00496606_m1) (Applied Biosystems). A standard nucleic acid
template and water were used as positive and negative controls,
respectively. Variations in RNA loading between reactions were
normalized by measurement of 18S ribosomal RNA (12). PCR was
performed under recommended thermal-cycling conditions: initially
50°C for 2 min and 95°C for 10 min (for enzyme activation), followed
by 40 cycles of 95°C for 15 s (cDNA denaturation) and 60°C for 1
min (probe annealing and extension). Data were collected using the
ABI PRISM 7700 and Sequence Detection System 1.9.1 (Applied
Biosystems) and analyzed using the comparative cycle threshold (Ct)
method (5).
Protein expression was evaluated by Western blotting. In brief,
protein extracts (50 g) were separated on 10% SDS-PAGE, trans-
ferred to nitrocellulose membranes, and incubated overnight with
polyclonal anti-GST- (1:500) or anti-GST- (1:500) antibodies
(Abcam, Cambridge, UK). Antibody binding was detected using
peroxidase-conjugated anti-goat IgG (1:2,000; Cell Signaling Tech-
nology, New England Biolaboratories, Hitchin, UK) and chemilumi-
nescence detection reagents (Amersham Biosciences, Little Chalfont,
UK). Equivalent loading of protein samples was confirmed by mouse
monoclonal anti--actin or anti--tubulin IgG (1:2,000; Sigma, St.
Louis, MO).
Analysis of lung cell viability. The effect of GST inhibition on cell
viability was evaluated under control conditions and in combination
with known oxidative stress conditions: hydrogen peroxide (H2O2),
tert-butyl hydroperoxide (tBH), or HR. Cell viability was analyzed by
the 2,5-diphenyltetrazolium bromide (MTT) reduction assay (26). The
optical density was measured as an index of cell viability, at 595 nm
using an MRX II plate reader (Magellan Biosciences, Surrey, UK).
To delineate the involvement of apoptosis vs. necrosis, we em-
ployed the annexin V-FITC, propidium iodide (PI) apoptosis/necrosis
detection kit (Sigma) and fluorescence-activated cell sorting (FACS)Calibur
flow cytometer (Becton Dickinson, Franklin Lakes, NJ) (38). Har-
vested cells were exposed to annexin V-FITC and PI in binding buffer
for 10 min in the dark at room temperature. Ten thousand events were
acquired and analyzed using the CellQuest program. Cellular debris
(with low forward- and side-light scatter) was excluded from the
analysis. FITC and PI fluorescence were detected at 525 nm and 620
nm, respectively. Quadrant statistics display annexin V and PI fluo-
rescence on the x- and y-axis, respectively, to identify viable cells
(negative for both annexin V and PI), apoptotic cells (positive for
annexin V, negative for PI), and late apoptotic dead cells (labeled with
both annexin V and PI). In most instances, apoptosis involves acti-
vation of caspase cascades. To further evaluate the role of apoptosis,
cells were treated in the presence or absence of 100 M zVAD
(Sigma), a broad-spectrum caspase inhibitor, and cell viability was
assessed by MTT assay.
Detection of oxidative stress. The influence of GST inhibition on
intracellular ROS was quantified using the ROS-sensitive fluorescent
dyes dihydrorhodamine (DHR) and 2=,7=-dihydrodichloro-fluorescein
diacetate (H2DCF-DA) (Invitrogen). MLE cells were preincubated for
30 min with 5 M DHR or 20 M H2DCF-DA before exposure to the
GST inhibitor EA for 1 h. Cells incubated in media alone or H2O2
served as negative and positive controls, respectively. Following
treatment, cells were harvested and resuspended in FACS wash buffer
(PBS supplemented with 5 mM EDTA, 2% FCS, and 0.1% sodium
azide). Samples were analyzed by flow cytometry at ex/em 495/525
nm. ROS quantification is reported as mean fluorescence intensity
(MFI). To evaluate the role of specific ROS in EA-induced cytotox-
icity, cells were preincubated for 1 h before EA treatment with the
ROS scavengers, N-acetylcysteine (NAC, 10 mM) or cell permeable
polyethylene glycol (PEG)-conjugated catalase (5,000 U/ml), or in-
hibitors of catalase (aminotriazole, ATZ, 10 mM), superoxide dismu-
tase (diethyldithiocarbamate, DETC, 1 mM), NADPH oxidase (diphe-
nyliodonium, DPI, 10 M), and nitric oxide synthase (nitro-L-arginine
methyl ester, L-NAME, 10 mM).
To evaluate the effect of GST inhibition on mitochondrial energet-
ics (relative levels of ATP, ADP, and AMP) and redox status (re-
flected by NAD and NADH ratios) (2, 21, 31), intracellular adenine
nucleotides were extracted from control and experimental cells as
described previously (47) and measured by reverse-phase high-per-
formance liquid chromatography (HPLC) and UV detection at 254
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nm. Briefly, samples were extracted with ice-cold perchloric acid (0.4
M) and neutralized with equimolar KOH. KClO4 was then precipi-
tated by centrifugation, and the supernatant was retained. Levels of
ATP, ADP, AMP, NAD, and ADPR, a breakdown product of
NADH following acid precipitation (21, 31), were analyzed using the
Agilent HPLC 1100 system. The mobile phase was 0.1 M potassium
dihydrogen phosphate (pH 6.0) with 0.15 M potassium chloride as
phase A and 15% acetonitrile in A as phase B with the Hypersil BDS
column and a flow rate 0.9 ml/min. The concentration of each
nucleotide was expressed as nanomoles per milliliter of extract with
reference to external standards used for calculation of concentrations
with reference to cell protein.
Protein carbonyls were estimated using a 2,4-dinitrophenylhydra-
zine (DNPH)-based procedure reported elsewhere (6, 33) with minor
changes. Briefly, cell lysates containing 0.1 mg protein were incu-
bated with 0.1% DNPH for 1 h at room temperature. Samples were
precipitated by addition of 30% trichloroacetic acid. Following cen-
trifugation, pellets were washed with ethanol:ethyl acetate (1:1 vol/
vol) and dissolved in 8 M guanidine-hydrochloride, 13 mM EDTA,
and 133 mM Tris pH 7.4. Optical density at 365 nm was determined
using a Hitachi U-2000 UV-VIS spectrophotometer. The carbonyl
content was calculated using Beer’s Law and an extinction coefficient
of 2.1  104 M/cm. Results are reported as nanomoles carbonyl per
milligram of protein.
Metabonomics. Global metabolic changes associated with GST
inhibition and oxidative stress were detected by metabonomic analysis
(3). Cellular extracts from control and experimental groups were
prepared for nuclear magnetic resonance (NMR) spectroscopy anal-
ysis. A Bruker DRX600 spectrometer (Bruker Biospin, Rheinstetten,
Germany) was employed, operating at 600.13 MHz 1H NMR fre-
quency and 283 K. Raw spectra were phased, baseline corrected,
calibrated to the trimethylsilylpropionic acid (TMSP) internal stan-
dard resonance (dH  0.00 ppm) and imported into Matlab (Student
2007; The MathWorks, Natick, MA). Spectra were normalized to
protein. Isolated metabolite signals within spectra were defined
through visual inspection, and their peak areas were determined.
Metabolite assignment was made using the Madison Metabolomics
Consortium Database (9).
Ex vivo IPL model. To investigate the physiological relevance of
our cellular findings, the direct impact of GST inhibitor EA on lung
physiological parameters was explored using an IPL mouse model.
All procedures were approved by the United Kingdom Home Office in
accordance with the Animals (Scientific Procedures) Act 1986, UK.
Male C57BL6 mice (Charles River Laboratories, Margate, UK) aged
8–12 wk were used for the ex vivo IPL system (Hugo Sachs Elek-
tronik; Harvard Apparatus, March-Hugstetten, Germany). In brief,
mice were anaesthetized, tracheostomized, and ventilated with a
custom-made mouse ventilator as previously described (35) at a
respiratory rate of 80 breaths/min. After thoracotomy/laparotomy and
heparinization, animals were exsanguinated, and the pulmonary artery
and left atrium were cannulated. Lungs were perfused in a nonrecir-
culating manner with prewarmed RPMI 1640 supplemented with 4%
BSA and 1.4 g/l NaCl (Sigma) to increase osmolarity, as described
previously (34). All experiments had an initial 15-min equilibration
period, and low tidal volume (VT) of 8 ml/kg was applied throughout
to minimize lung injury development. Peak inspiratory pressure (PIP),
positive end-expiratory pressure, and gas flow were monitored con-
tinually via transducers connected to a PowerLab data acquisition
system (AD Instruments, Chalgrove, UK). Data were analyzed using
Chart software (version 5.5.6, AD Instruments). Accurate measure-
ments of VT, respiratory system compliance, and resistance were
determined by end-inflation occlusion at 30-min intervals.
Lung permeability index. The pulmonary endothelial/epithelial per-
meability to a fluorescence-labeled albumin was assessed, using an
adaptation of a previously reported fluorescence-based method for
measuring vascular leak into the alveolar space (45). Following a 2-h
perfusion, 1 mg/ml Alexa Fluor 594-conjugated albumin (Invitrogen)
was added to the perfusate in the recirculating circuit. After 30 min,
the perfusate was collected from the reservoir and stored in the dark.
Thereafter, the circuit was switched to a nonrecirculating system for
5 min to wash out the residual fluorescence from the lung vasculature.
Bronchoalveolar lavage fluid (BALF) was obtained as described
previously (44). Fluorescence levels of perfusate, BALF, and lung
tissue were measured using a fluorescence plate reader (Flx-800;
BioTek Instruments, Potton, UK) at absorption 590 nm. An index of
lung endothelial and epithelial permeability was then estimated by the
ratio of lung tissue:perfusate and lavage fluid:perfusate fluorescent
signal, respectively. Protein levels in BALF were also quantified as
another index of pulmonary permeability.
Statistics. Data are reported as the means of repeated experiments	 SD.
The majority of statistical analyses were performed using Prism
software (version 4.0; GraphPad, La Jolla, CA). Metabonomics data
were analyzed by SPSS 17 (Chicago, IL). Comparison of three or
more variables was carried out by either one-way ANOVA or repeat-
ed-measure ANOVA with multicomparisons/post hoc tests (including
Bonferroni) where appropriate. Statistical significance of metabonom-
ics data was assessed by Kruskal-Wallis test. Multiple comparisons of
metabonomics data were controlled for using the Benjamini-Hoch-
berg procedure, with accepted false discovery rate 0.05. A P value

0.05 was considered significant.
RESULTS
EA and CA inhibit GST activity and decrease lung cell
viability. To study the efficiency of GST inhibition, pure GST
and MLE cell lysates (prepared from 4  106 cells) were
incubated with increasing concentrations of GST inhibitors at
37°C for 1 h. Both EA and CA effectively inhibited GST
activity in pure GST as well as MLE cell lysates in a concen-
tration-dependent manner with an IC50 of 25 M and 1 mM,
respectively. Exposure of MLE cells to increasing concentra-
tions of EA and CA revealed major morphological changes and
a concentration-dependent reduction in cell viability, assessed
by MTT assay. After 5-h exposure, 100 and 300 M EA
reduced viability to 92	 7% and 13	 7% of control (Fig. 1A).
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Fig. 1. Influence of increasing concentrations
of glutathione-S-transferase (GST) inhibitors
on murine lung epithelium (MLE) cell viabil-
ity. Viability was assessed by 2,5-diphe-
nyltetrazolium bromide (MTT) assay following
5-h ethacrynic acid (EA) exposure (A) and 24-h
treatment with caffeic acid (CA) (B); n 4–6;
*P 
 0.05 vs. untreated control.
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Similar findings were obtained following 24-h treatment with
CA, which led to a 55 	 35% reduction in cell viability at 1
mM (Fig. 1B). To explore whether GST inhibitor-induced
cytotoxicity was limited to epithelial cells or applicable to
other cell types in the lung, we have explored the effect of EA
on primary mouse lung endothelial cells available in our
laboratory. Exposure of these cells to increasing concentrations
of EA for 5 h showed that the endothelial cell viability was also
compromised by 300 M EA (74 	 7% of control).
Apoptotic nature of cell death. The nature of EA-induced
cell death was investigated by staining MLE cells with annexin
V and PI, and fluorescently labeled cells were identified using
FACS (Fig. 2). Untreated cells showed 90% cell viability,
which decreased to 74% and 17% following 3- and 5-h incu-
bation with 300 M EA, respectively. This was associated with
a significant rise in the necrotic cell population, i.e., those
exhibiting PI fluorescence in the absence of annexin V label-
ing. Moreover, after 5 h of treatment, the percentage of annexin
V-fluorescent cells increased by 10-fold, indicative of an
apoptotic cell population. Cells exhibiting both annexin V and
PI increased from 1 to 57% of total population.
To identify whether caspases are involved in EA-induced
cell injury, MLE cells were incubated with zVAD (100 M)
before treatment with 0–300 M EA (Fig. 3A). As a positive
control, we evaluated whether zVAD preincubation influenced
cell death induced by a combination of tumor necrosis factor-
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Fig. 2. Apoptotic/necrotic cells determined by annexin V (Ann V)/propidium iodide (PI) staining and flow cytometry. Cells were treated with 300 M EA for
the indicated times, and untreated cells were used as a negative control. A representative forward-scatter/side-scatter gating strategy is illustrated to exclude cell
debris from the analysis. The gated cell population was then acquired for Ann V and PI staining. Viable: Ann V and PI negative. Apoptotic: Ann V positive and
PI negative. Necrotic: PI positive. Apoptotic/Necrotic: Ann V and PI positive.
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Fig. 3. Influence of caspase inhibitor zVAD on
stress-induced MLE cell death. MLE cells were
exposed to stresses EA (A) and tumor necrosis
factor- (TNF-)/cycloheximide (CHX) (B)
for 5 and 24 h, respectively; n  3–6; *P 

0.05 vs. vehicle control (i.e., in the absence of
zVAD).
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(TNF-)/cycloheximide treatment (Fig. 3B). Whereas zVAD
preincubation attenuated cell death induced by TNF/cyclohex-
imide (cell viability of 24% vs. 5%), it had no influence on
EA-induced cell death.
Potentiation of stress-induced cytotoxicity by GST inhibitors.
H2O2 and tBH alone resulted in a concentration-dependent
reduction in cell viability over 5 h. These stress-induced
cytotoxic effects were significantly potentiated by subtoxic
concentrations of GST inhibitors, namely 100 M EA (Fig. 4,
A and C) and 0.5 mM CA (Fig. 4B). For instance, cell
viability was reduced from 64 	 24% after 0.5 mM H2O2
treatment to 26 	 14% and 31 	 5% in the presence of EA
and CA, respectively, compared with untreated controls.
Similarly, EA exacerbated tBH-induced cell death. For
instance, following 1 mM tBH treatment, the presence of
GST inhibitor reduced viability from 71 	 4% to 23 	 14%
of untreated controls.
Before studying the influence of EA on MLE cell survival in
the setting of HR, we explored the influence of increasing
duration of HR on cell viability. Interestingly, hypoxia up to 24
h and reoxygenation up to 6 h did not appear to compromise
MLE cell viability measured as MTT activity (Fig. 4D). Injury,
however, was unmasked in the presence of EA. For instance,
25 M EA had no measurable effect during normoxia, but it
reduced viability of hypoxic control by 19 	 9%. In addition,
50 M EA reduced cell viability by 35 	 11% in normoxic
conditions but led to a 77 	 10% decrease in viability during
HR conditions.
Oxidative stress is involved in EA-induced cytotoxicity. To
test the hypothesis that EA-induced cell injury is mediated by
an altered intracellular redox state (1, 37), we initially moni-
tored oxidative stress with redox-sensitive fluorescent dyes.
Exposure of MLE cells to EA (300 M) for 1 h increased the
MFI of DHR123 and DCF by over 2- and 30-fold, respectively,
compared with basal levels (Fig. 5, A and B). In the control
experiment, EA had no direct effect on dye autofluorescence in
the absence of MLE cells after 3 h (data not shown).
To assess global intracellular redox state, nucleotides NAD
and ADPR (the breakdown product of NADH) were measured
by HPLC and UV detection, and their ratio was calculated.
Figure 5C shows that redox state was altered in a concentra-
tion-dependent manner by EA exposure alone, causing a de-
crease in NAD/NADH ratios to 11% of untreated control by
300 M EA. Furthermore, H2O2 also reduced NAD/NADH
ratios, and this effect was potentiated by EA (43 vs. 28% of
untreated control following 3-h treatment with H2O2 in the
absence or presence of 100 M EA, respectively, P 
 0.05)
(Fig. 5D).
To further evaluate intracellular oxidative stress in the set-
ting of GST inhibition, excess formation of carbonylated pro-
tein was monitored spectrophotometrically. Exposure of cells
to 100 M EA alone did not affect steady-state levels of protein
carbonylation (Fig. 5E). H2O2 alone increased protein carbon-
yls from 1.2 	 0.2 to 2.6 	 0.3 nmol/mg, and EA significantly
enhanced H2O2-induced increase in protein carbonyls from
two- to fourfold, compared with untreated control after 3 h of
treatment (Fig. 5E).
Inhibitors of H2O2 and NO do not attenuate EA-induced cell
injury. We have attempted to further characterize the reactive
species involved in EA-mediated lung cell injury. Specifically,
to test the hypothesis that increased generation of H2O2 is
responsible for EA-induced cell injury (37), we investigated
the effect of modulating catalase activity by preincubating cells
with either cell-permeable (PEG-conjugated) catalase (5,000
U/ml) or the catalase inhibitor ATZ (20 mM). Although cata-
lase completely abolished the cytotoxic effect of H2O2 (Fig.
6B), EA-induced cell injury was unaffected by PEG catalase
(Fig. 6A). ATZ-induced catalase inhibition also had no influ-
ence on EA cytotoxicity (Fig. 6C).
To further evaluate the role of intracellular oxidative stress
in GST inhibitor-induced cytotoxicity, we preincubated cells
with a variety of inhibitors, affecting well-known oxidative
stress pathways and the broad-spectrum antioxidant NAC.
Exposure of cells to L-NAME and DPI, targeting ROS gener-
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Fig. 4. Impact of GST inhibition on MLE cell
response to oxidative stress conditions. Influ-
ence of chemical stressors hydrogen peroxide
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ators nitric oxide synthase and NADPH oxidase, respectively,
had no impact on EA-induced cell death. However, cells
preincubated with the ROS scavenger NAC (10 mM) fully
protected cells from injury induced by 300 M EA (92 	 6%
vs. 13 	 7% of untreated control, P 
 0.05) (Fig. 7C) and 1
mM CA (84 	 6% vs. 45 	 35% of untreated control, P 

0.05) (Fig. 7D). Furthermore, pretreatment with NAC com-
pletely abolished EA-induced increased fluorescence (MFI) of
ROS-sensitive dyes DHR123 and DCF (45 	 8% vs. 14 	 2%
and 352 	 49% vs. 9 	 1%, P 
 0.05) (Fig. 7, A and B).
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GST inhibition has no influence on mitochondrial energetics. To
investigate whether EA mediates cellular injury through oxi-
dative stress affecting mitochondrial energetics, we determined
ATP/ADP nucleotide ratios in extracts of cells exposed to EA,
H2O2, or both treatments over 3 h and 5 h. In control cells, ATP
levels were 27.6 	 1.7 nmol/mg protein, and ADP levels were
2.1 	 0.3 nmol/mg protein. ATP/ADP ratios were not affected
by EA exposure alone, with ratios of 17 	 2, 15 	 1, and
20 	 4 following exposure to 100 M, 200 M, and 300 M
respectively for 3 h. By contrast exposure of cells to H2O2,
used as a positive control, significantly reduced ATP/ADP
ratio from 12 	 4 to 5 	 3 after 5 h (P 
 0.05). EA (100 M)
had no influence on H2O2-induced reduction in ATP/ADP ratio
(5 	 3 vs. 3 	 2 nmol/mg protein, P  0.05) (Fig. 8).
Changes in intracellular metabonomic profile. Metabonom-
ics was employed to explore the impact of GST inhibitor EA
and oxidative stress on global metabolic profile. 1H-NMR
spectra acquired from control, EA-, H2O2-, and H2O2 
EA-treated MLE cells. Spectral regions that could be assigned
to specific metabolites, which showed visual evidence of vari-
ation in peak intensities, were subject to further analysis. Table
1 shows the fold change of assigned metabolites significantly
affected by oxidative stress and EA. Changes in metabolite
levels were enhanced after dual treatment with H2O2 and EA
compared with treatment with EA or H2O2 alone. Metabolites
with the most prominent changes in response to treatment with
H2O2 and EA included glutamate (4.5-fold increase), threonine
(4.2-fold increase), and tyramine (3.5-fold increase). Metabo-
nomics also revealed a number of unassigned metabolites
whose levels were altered by H2O2 and EA exposure.
Genetic manipulation of GST- impacts on cell viability in
control and stress conditions. To develop a cellular model of
GSTM1-null and GSTP1 Ile105 polymorphisms, we investi-
gated the impact of specific GST isoform knockdown by RNA
interference. The efficiency of siRNA-mediated RNA knock-
down was assessed by real-time PCR, 48 h following transfec-
tion. Cells transfected with GST- and - siRNA showed 87	 4%
and 90 	 3% knockdown of RNA expression, respectively,
with no significant effect of control scrambled siRNA (Fig.
9A). Protein expression of GST- and - was evaluated by
Western blotting 48 and 72 h after transfection. Whereas
GST- protein expression was abundant in A549 cell line and
expressed in whole mouse lung, the expression of this protein
was low in MLE cells (Fig. 9C), and therefore the influence
of GST knockdown could not be monitored by Western
blotting. However, protein bands indicate that GST- pro-
tein is absent in cells transfected with GST- siRNA at 48
and 72 h (Fig. 9B).
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Oxidative stress was simulated by exposure of cells to H2O2
(3 h) or hypoxia (24 h) followed by reoxygenation for 6 h, and
cell viability was assessed by MTT assay. GST- siRNA
knockdown had no significant effect on cell viability alone or
in response to H2O2 or HR. Interestingly GST- knockdown
resulted in a 16 	 11% reduction in viability of control cells
(Fig. 10A). Moreover, the viability of GST- siRNA-trans-
fected cells was significantly less than cells transfected with
scrambled siRNA in the presence of 1 mM H2O2 (28 	 10%
vs. 49 	 21%, P 
 0.05) (Fig. 10A). As in previous experi-
mental series, HR did not compromise MLE cell viability in
control conditions (scrambled siRNA). However, lack of
GST- isoform resulted in a 20 	 18% reduction in viability
(P 
 0.05) (Fig. 10B).
EA affects lung mechanics and permeability in the isolated
perfused lung model. To begin to explore the physiological role
of GST, we used an ex vivo IPL model and supplemented the
perfusate with GST inhibitor EA. Pulmonary mechanics were
monitored at 15-min intervals over the 2-h perfusion period.
Physiological parameters remained stable and similar to con-
trol values for 90 min of perfusion. However, EA supple-
mentation resulted in a significant increase in plateau pressure
(34%, P 
 0.05) at 120 min (Fig. 11A). A similar increase in
PIP was also observed (31%) at 120 min although this did not
reach significance. We observed similar significant increases in
pulmonary resistance (29	 19, P
 0.05) and elastance (33	
24%, P 
 0.05) at 120 min in the presence of EA (Fig. 11, B
and C).
Lung permeability was assessed via measurement of fluo-
rescence-labeled albumin translocation from blood to alveolar
space. BALF protein content was measured as an additional
index of pulmonary edema. EA gave a threefold rise in the
BALF:perfusate ratio, an index of epithelial barrier permeabil-
ity (0.017 	 0.009 vs. 0.052 	 0.016, P 
 0.05) (Fig. 11D),
and a sixfold increase in BALF protein levels (0.7	 0.4 mg/ml
vs. 4.3 	 2.4 mg/ml, P 
 0.05) (Fig. 11E).
DISCUSSION
There is increasing evidence from clinical literature that
GST polymorphism and altered GST expression may impact
on lung oxidative stress and outcomes of lung injury (7, 25,
32). Experimental data show that exogenous supplementation
of recombinant GST enzymes impacts positively on oxidative
events and inflammation (23), but the role of endogenous GSTs
is less well known. The primary objective of this study was to
explore the influence of attenuated endogenous GST activity in
lung epithelial cells on cellular responses relevant to the setting
of ischemia and reperfusion injury.
In the present study, we demonstrated that both pharmaco-
logical inhibition of endogenous GSTs and genetic knockdown
of GST isoforms affected epithelial cell injury. First, two well
recognized GST inhibitors, EA and CA (28, 29, 49), compro-
mised cell viability in a concentration- and time-dependent
manner. Concentrations inducing such cytotoxicity were com-
Table 1. Fold change of selected metabolites significantly
affected by EA and oxidative stress
EA H2O2 H2O2  EA P*
Threonine 2.0 2.4 4.2 0.016
Glutamate 1.6 2.1 4.5 0.016
Tyramine 1.5 1.9 3.5 0.019
Phenylalanine 1.5 2.0 3.2 0.022
Lactate 1.4 1.6 2.2 0.025
Pyruvate 1.4 1.1 1.5 0.022
Ox-glutathione 1.3 1.2 1.6 0.025
Alanine 1.2 1.2 1.4 0.025
Aspartate 1.1 1.2 1.6 0.034
Free choline 1.1 1.3 1.5 0.016
Glycerophosphocholine 1.3 1.0 1.8 0.024
Cells were exposed to either or both ethacrynic acid (100 M) (EA) and/or
oxidative stress (0.8 mM H2O2) over a 5-h period (n  3). *Kruskal-Wallis
test. Multiple comparisons were controlled for using the Benjamini-Hochberg
procedure, with accepted false discovery rate of 0.05.
Fig. 9. Efficiency of GST- and - siRNA
and impact of GST isoform knockdown on
MLE cells exposed to stress. A: GST- RNA
expression measured by RT-PCR 48 h after
cell transfection with scrambled, , and 
siRNA; n  4; *P 
 0.05 vs. scrambled
control. B: representative blot (n  3) of
GST- protein expression assessed by West-
ern blotting 48 and 72 h after cells were
nontransfected (NT), or transfected (Tx)
with scrambled or GST- siRNA. C: West-
ern blot analysis of GST- and - protein
expression in MLE and A549 cell lysates
and whole mouse lung homogenate (as ad-
ditional controls); n  2.
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parable to those inhibiting both pure GST and endogenous
GST activity in MLE cell lysates. Although GST inhibitor-
induced cell death was unexpected, such a response is not
unprecedented, as similar observations were made in colon
cancer cell lines and human leukemia cell lines (1, 37). In
addition to causing cell injury themselves, subtoxic concentra-
tions of EA and CA potentiated cytotoxicity induced by chem-
ical stressors H2O2 and tBH. Although MLE cells tolerated
long periods of hypoxia and subsequent reoxygenation, injury
was unmasked in the presence of subtoxic concentrations of the
GST inhibitor.
Genetic attenuation of GST- following siRNA transfection
resulted in a decrease in viability of nonstressed cells and
rendered cells more susceptible to H2O2-induced injury and
HR conditions. Although the magnitude of this response was
less than those with pharmacological inhibition, this is remark-
able considering the redundancy of intracellular GST enzymes.
Although our experiments may suggest a more specific
involvement of GST-, as knockdown of GST- did not have
similar effects in MLE cells, these results should be interpreted
with caution. First, we only targeted one GSTM gene, and
other genes in this class could have compensated for such
effect. Second, the abundance of GST- in MLE cells was
lower than GST-, and the effect of knockdown on cell
viability, therefore, could have been related to protein abun-
dance rather than specific activity. Nevertheless, our results
suggest that endogenous GST- could be important for normal
homeostasis and viability of lung epithelial cells and in the
intrinsic survival mechanisms of these cells under oxidative
stress conditions and HR.
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Apoptosis of lung epithelial cells represents a potentially
important mechanism contributing to the development of ALI
in various settings. Two previous studies evaluated the role of
apoptosis in EA-induced cell death in cancer cell lines and
reported conflicting results (1, 37). By using flow cytometry,
we observed a slight increase in the percentage of purely
apoptotic cells following EA exposure; however, the majority
of cells exhibited both annexin V and PI fluorescence, repre-
senting a late apoptotic/necrotic cell death. To further define
the role of classical apoptotic events in EA-induced cell death,
we investigated the involvement of caspases. EA-induced cell
death was not affected by the caspase inhibitor, which in turn
attenuated the response to another death stimulus (TNF in the
presence of cycloheximide). Thus we concluded that EA-
induced cytotoxicity is unlikely to be driven by a classical
caspase-mediated apoptotic pathway. However, we cannot ex-
clude the involvement of a caspase-independent apoptotic
cascade, such as that mediated by apoptosis-inducing factor.
We have considered the possibility that the GST inhibitors
increased intracellular oxidative stress, either through inhibi-
tion of GST leading to an accumulation of intracellular ROS or
through direct activation of ROS-producing pathways. In pre-
vious studies, ROS accumulation has been implicated in EA-
induced cell death (37); thus we investigated the influence of
EA on various aspects of oxidative stress using complementary
approaches. EA caused a significant increase in both DHR123
(2-fold) and DCF (30-fold) fluorescence in MLE cells. Al-
though the exact mechanism responsible for the increased
fluorescence and differential response with these probes re-
mains unknown, the data provide evidence linking EA expo-
sure to intracellular oxidative reactions. Although the limita-
tion of DCF in detecting intracellular H2O2 is well established
(15, 40), it is possible that EA-induced redox events may
involve H2O2-triggered downstream oxidative reactions. In-
deed, one previous study concluded that EA-induced cytotox-
icity was mediated by H2O2 (37). In our experiments, however,
H2O2 caused a dissimilar pattern of DCF/DHR123 increase
compared with EA, and EA-induced cell injury was not pre-
vented by PEG catalase or potentiated by endogenous catalase
inhibition. A limitation of these experiments is that intracellu-
lar catalase activity was not measured. Furthermore, the appli-
cation of DETC may not have been specific, as it affects all
copper-containing molecules, not just CuZnSOD, and would
not be expected to affect MnSOD. The DHR response indicates
the possible involvement of reactive nitrogen species; how-
ever, L-NAME had no effect on EA responses. Therefore, we
do not think that either H2O2 or nitric oxide plays a significant
role in GST inhibitor-induced intracellular oxidative stress and
cell death.
To further substantiate the role of redox events, we deter-
mined global intracellular redox state by measuring the prom-
inent intracellular NAD/NADH redox couples. Cellular and
mitochondrial redox homeostasis is intricately connected and
regulated by several redox-sensitive couples, including gluta-
thione/glutathione disulphide and NAD/NADH (2). We have
shown the ability of EA to alter NAD/NADH ratio and a
tendency to potentiate H2O2-induced redox changes. Further-
more, although low concentrations of EA did not cause protein
carbonyl formation, EA significantly enhanced this reaction by
H2O2. Taken together, these independent experiments suggest
an association between EA-induced intracellular oxidative
stress and cellular injury.
Interestingly, preincubation of cells with NAC prevented
both EA- and CA-induced increase in ROS, as well as the
resulting cell death. There may be several explanations for this
phenomenon. First, NAC may interfere with the GST inhibitors
themselves in the extracellular space. Although we cannot
exclude such possibility with certainty, the fact that NAC
inhibited the actions of two chemically distinct pharmacolog-
ical GST inhibitors makes this scenario less likely. Moreover,
Aizawa et al. (1) also concluded that the influence of NAC on
EA-induced responses in their experiments was not related to
direct interaction with EA (1). The second explanation is that
NAC could augment intracellular antioxidant capacity by en-
tering the cells and may help scavenge reactive species respon-
sible for fluorescent dye oxidation and cellular injury. Third,
NAC as a precursor of glutathione may augment or replenish
depleted glutathione levels. Indeed, DCF fluorescence is mod-
ulated by intracellular glutathione, and glutathione is one of the
major defense mechanisms guarding against intracellular oxi-
dative stress. Finally, the effects of NAC may be unrelated to
its antioxidant properties, as it is a very broad-spectrum reduc-
ing agent.
The effects of GST inhibitors on mitochondrial energetics
and its influence on cell injury and necrosis were considered.
As ATP/ADP ratio remained unchanged even by high concen-
trations of EA, we have concluded that mitochondrial dysfunc-
tion is an unlikely mediator of EA-induced cell death. Meta-
bonomics profiling has provided a preliminary insight into the
metabolic pathways affected in cells exposed to oxidant stress
and/or GST inhibition. Initial multivariate analysis of acquired
NMR spectral dataset separated treatment groups, suggesting
that both oxidative stress and GST inhibition produce time- and
treatment-specific changes in the global intracellular metabo-
lome. Targeted spectral analysis identified specific changes in
cellular metabolites in response to defined oxidative stress by
H2O2, and many of these have close links to energy metabo-
lism and cellular redox status and adaptation.
These metabolites have been previously reported to be
associated with various ischemic, inflammatory, and oxidative
conditions. For instance, glutamate acts as a neurotransmitter
in various oxidative stress-related neurodegenerative condi-
tions and has been linked to the development of lung injury in
animal models of hyperoxia and sepsis (10, 30, 36). In addi-
tion, threonine levels increase in response to hypoxic injury
(42), and elevated levels of tyramine have been reported
following myocardial infarction, acute cystitis, and smoking
(22, 27, 43). Further experimental work and bioinformatics
analysis is required to determine the precise role of these
metabolites in ischemia, oxidative stress, and inflammation.
It is clear that multiple oxidative stress-induced changes
were modified by cotreatment with the GST inhibitor. By
detecting differences in a number of unassigned peaks of the
metabonomic spectra, our findings also reveal potentially novel
metabolic signatures of oxidative stress and GST inhibition.
In addition to the in vitro studies, experiments were per-
formed to explore the physiological consequences of GST
inhibition. A mouse ex vivo lung perfusion model documented
the direct pulmonary influence of EA supplementation. EA
caused time-dependent changes in multiple aspects of physi-
ology, in particular, increased respiratory elastance, resistance,
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and pulmonary permeability. The experimental conditions did
not affect perfusion pressure. These preliminary findings sug-
gest that EA caused a degree of specific injury to lung com-
partments, most likely microvascular and epithelial permeabil-
ity.
Despite the strengths of our investigation covering multiple
aspects of endogenous GST-related oxidative stress, cellular
energetics, and metabolism using complementary pharmaco-
logical and genetic approaches and expanding the in vitro
findings to in vivo physiology, the study has limitations. First,
our investigation focuses primarily on epithelial cells. We,
however, realize that hypoxia/reperfusion injury requires dam-
age to both epithelial and endothelial linings of the lung and the
endothelium must be damaged for the increase in permeability
and changes in lung mechanics to occur. There is published
evidence regarding the roles for GST enzymes in modulating
cellular responses of vascular endothelial cells and signaling
pathways during oxidative stress (46, 48). Moreover, we show
that the cytotoxic effect of EA is not restricted to epithelial
cells, but the phenomenon is also observed in mouse endothe-
lial cells. Our IPL data also demonstrate selective influence of
EA on endothelial function as pulmonary artery pressure;
hence pulmonary vascular resistance and vasoactivity was not
altered, but microvascular permeability was increased. This
phenomenon may be related to published evidence of GST
regulating tight junction composition and organization (46).
Another limitation relates to using fluorescence markers of
oxidative stress, which is liable to well-known limitations and
potential artifacts (15, 40). We realize that fluorescent dyes
only provide general information on the ability of the cells to
oxidize the dyes and that the exact mechanism of these phe-
nomena remains to be fully elucidated. However, we did not
rely completely on these probes but assessed additional aspects
of oxidative stress and multiple pharmacological strategies.
A further limitation is that most of the GST inhibition
experiments used pharmacological tools that have the potential
for off-target effects. Nevertheless, we obtained similar data
using chemically distinct inhibitors and complemented the
pharmacology with genetic approaches. Finally, our metabo-
nomics and in vivo studies are preliminary in nature. Never-
theless, the metabolic profiling experiments have provided us
with the first description of oxidative stress metabolome in
lung epithelial cells. Furthermore, the physiological experi-
ments clearly documented promising aspects of lung mechan-
ics and permeability where endogenous GST may be essential.
These may be helpful in the design of in vivo experiments for
future studies, perhaps using GST conditional cell-specific
knockout mice.
This work and other published literature should underpin
more preclinical work with animal models toward new ap-
proaches to address lung injury in humans. The recognition
that GST genes are consistently altered in various animal
models of lung injury and are among the top genes that
accurately predict development of primary graft failure in lung
transplant donors (19) certainly points toward these promising
directions. Our pilot genetic data may also highlight a role of
specific GST gene polymorphism in the development of peri-
operative myocardial infarction (20), thus extending the para-
digm beyond lung ischemia reperfusion injury.
In summary, we have demonstrated that alteration of GST
activity disturbs the intracellular redox status, most likely
through accumulation of secondary oxidative stress products.
Furthermore, our findings suggest that GST inhibitors or spe-
cific attenuation of GST- enhance H2O2-induced cell injury
attributable to increased oxidative stress and subsequent met-
abolic derangements. The totality of evidence gathered in these
studies demonstrates that GST activity is potentially involved
in the survival of cultured lung epithelial cells under stress
conditions. On the basis of our pilot physiological data, endog-
enous GST may play an important role in lung microvascular
and epithelial regulation of permeability and lung mechanics
and may have important clinical implications.
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